These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response. Gangaev A; Rozeman EA; Rohaan MW; Isaeva OI; Philips D; Patiwael S; van den Berg JH; Ribas A; Schadendorf D; Schilling B; Schumacher TN; Blank CU; Haanen JBAG; Kvistborg P Proc Natl Acad Sci U S A; 2021 Oct; 118(43):. PubMed ID: 34670835 [TBL] [Abstract][Full Text] [Related]
7. T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient. Wieland A; Kamphorst AO; Adsay NV; Masor JJ; Sarmiento J; Nasti TH; Darko S; Douek DC; Xue Y; Curran WJ; Lawson DH; Ahmed R Cancer Immunol Immunother; 2018 Nov; 67(11):1767-1776. PubMed ID: 30167863 [TBL] [Abstract][Full Text] [Related]
11. Improvement of PD-1 Blockade Efficacy and Elimination of Immune-Related Gastrointestinal Adverse Effect by mTOR Inhibitor. Bai X; Wang X; Ma G; Song J; Liu X; Wu X; Zhao Y; Liu X; Liu Z; Zhang W; Zhao X; Zheng Z; Jing J; Shi H Front Immunol; 2021; 12():793831. PubMed ID: 34987517 [TBL] [Abstract][Full Text] [Related]
12. TCR Repertoire Diversity of Peripheral PD-1 Han J; Duan J; Bai H; Wang Y; Wan R; Wang X; Chen S; Tian Y; Wang D; Fei K; Yao Z; Wang S; Lu Z; Wang Z; Wang J Cancer Immunol Res; 2020 Jan; 8(1):146-154. PubMed ID: 31719056 [TBL] [Abstract][Full Text] [Related]
13. CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases. Yuan J; Ginsberg B; Page D; Li Y; Rasalan T; Gallardo HF; Xu Y; Adams S; Bhardwaj N; Busam K; Old LJ; Allison JP; Jungbluth A; Wolchok JD Cancer Immunol Immunother; 2011 Aug; 60(8):1137-46. PubMed ID: 21465316 [TBL] [Abstract][Full Text] [Related]
15. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Tumeh PC; Harview CL; Yearley JH; Shintaku IP; Taylor EJ; Robert L; Chmielowski B; Spasic M; Henry G; Ciobanu V; West AN; Carmona M; Kivork C; Seja E; Cherry G; Gutierrez AJ; Grogan TR; Mateus C; Tomasic G; Glaspy JA; Emerson RO; Robins H; Pierce RH; Elashoff DA; Robert C; Ribas A Nature; 2014 Nov; 515(7528):568-71. PubMed ID: 25428505 [TBL] [Abstract][Full Text] [Related]
16. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy. Chowell D; Morris LGT; Grigg CM; Weber JK; Samstein RM; Makarov V; Kuo F; Kendall SM; Requena D; Riaz N; Greenbaum B; Carroll J; Garon E; Hyman DM; Zehir A; Solit D; Berger M; Zhou R; Rizvi NA; Chan TA Science; 2018 Feb; 359(6375):582-587. PubMed ID: 29217585 [TBL] [Abstract][Full Text] [Related]
17. CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit. Yuan J; Gnjatic S; Li H; Powel S; Gallardo HF; Ritter E; Ku GY; Jungbluth AA; Segal NH; Rasalan TS; Manukian G; Xu Y; Roman RA; Terzulli SL; Heywood M; Pogoriler E; Ritter G; Old LJ; Allison JP; Wolchok JD Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20410-5. PubMed ID: 19074257 [TBL] [Abstract][Full Text] [Related]
18. Assessing clonal changes in T cells over time following immunotherapy is a breeze with Cyclone. Cillo AR; Kirkwood JM Cancer Cell; 2024 Sep; 42(9):1491-1493. PubMed ID: 39255774 [TBL] [Abstract][Full Text] [Related]
19. Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events. Müller B; Bärenwaldt A; Herzig P; Zippelius A; Maul LV; Hess V; König D; Läubli H Front Immunol; 2023; 14():1125111. PubMed ID: 37122748 [TBL] [Abstract][Full Text] [Related]
20. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade. House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]